tiprankstipranks
Trending News
More News >
Hightide Therapeutics Inc (HK:2511)
:2511
Hong Kong Market

Hightide Therapeutics Inc (2511) Financial Statements

Compare
1 Followers

Hightide Therapeutics Inc Financial Overview

Hightide Therapeutics Inc's market cap is currently HK$1.38B. The company's EPS TTM is HK$-0.2951542233; its P/E ratio is -3.89; Hightide Therapeutics Inc is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit¥ 0.00¥ -2.02M¥ -1.30M¥ -1.56M
Operating Income¥ -444.75K¥ -456.39M¥ -226.08M¥ -132.08M
EBITDA¥ -444.22K¥ -1.04B¥ -229.56M¥ -131.80M
Net Income¥ -381.79K¥ -1.04B¥ -190.24M¥ -221.15M
Balance Sheet
Cash & Short-Term Investments¥ 490.52M¥ 735.70M¥ 828.33M¥ 763.91M
Total Assets¥ 559.93M¥ 795.04M¥ 855.82M¥ 777.23M
Total Debt¥ 77.91M¥ 16.43M¥ 1.27B¥ 1.01B
Net Debt¥ -232.84M¥ -591.78M¥ 846.32M¥ 248.32M
Total Liabilities¥ 135.76M¥ 92.26M¥ 1.33B¥ 1.05B
Stockholders' Equity¥ 424.17M¥ 702.77M¥ -470.53M¥ -271.77M
Cash Flow
Free Cash Flow¥ -299.46M¥ -368.56M¥ -172.90M¥ -90.12M
Operating Cash Flow¥ -294.81M¥ -367.67M¥ -172.71M¥ -88.40M
Investing Cash Flow¥ -89.72M¥ 321.64M¥ -415.66M¥ 1.59M
Financing Cash Flow¥ 54.79M¥ 399.46M¥ 46.03M¥ 493.98M
Currency in CNY

Hightide Therapeutics Inc Earnings and Revenue History

Hightide Therapeutics Inc Debt to Assets

Hightide Therapeutics Inc Cash Flow

Hightide Therapeutics Inc Forecast EPS vs Actual EPS